Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats

Journal of Nutritional Biochemistry

Volumn 24, Issue 12, 2013, Pages 2127-2137

  Chang, Cheng Yi ^a   Kuan, Yu Hsiang ^b   Li, Jian Ri ^c   Chen, Wen Ying ^d   Ou, Yen Chuan ^c   Pan, Hung Chuan ^c   Liao, Su Lan ^c   Raung, Shue Ling ^c   Chang, Chen Jung ^e   Chen, Chun Jung ^c,d,f,g,h  

^a FENG YUAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^e CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^f TUNGHAI UNIVERSITY   (Taiwan)

^g HUNGKUANG UNIVERSITY   (Taiwan)

^h CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

DHA; Neuroinflammation; Neuroprotection; Stroke

Indexed keywords

DOCOSAHEXAENOIC ACID; HEME OXYGENASE 1; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BEHAVIOR DISORDER; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL ACTIVATION; CELL INFILTRATION; CELLULAR INFLAMMATORY RESPONSE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ACTIVATION; MACROPHAGE; MALE; MICROGLIA; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

RATTUS;

DHA; NEUROINFLAMMATION; NEUROPROTECTION; STROKE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD-BRAIN BARRIER; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; GENE EXPRESSION REGULATION; HEME OXYGENASE (DECYCLIZING); INFLAMMATION; INTERFERON-GAMMA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICROGLIA; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84887610342     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.08.004     Document Type: Article

References (54)

1. Cho S., Liu D., Gonzales C., Zaleska M.M., Wood A. Temporal assessment of caspase activation in experimental models of focal and global ischemia. Brain Res 2003, 982:146-155.
2. Choi D.W. Excitotoxic cell death. J Neurobiol 1992, 23:1261-1276.
3. Gursoy-Ozdemir Y., Can A., Dalkara T. Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 2004, 35:1449-1453.
4. Vila N., Castillo J., Dávalos A., Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000, 31:2325-2329.
5. Gelderblom M., Leypoldt F., Steinbach K., Behrens D., Choe C.U., Siler D.A., et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857.
6. Zhou W., Liesz A., Bauer H., Sommer C., Lahrmann B., Valous N., et al. Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models. Brain Pathol 2013, 23:34-44.
7. Gelderblom M., Leypoldt F., Lewerenz J., Birkenmayer G., Orozco D., Ludewig P., et al. The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice. J Cereb Blood Flow Metab 2012, 32:835-843.
8. Lee M.Y., Kuan Y.H., Chen H.Y., Chen T.Y., Chen S.T., Huang C.C., et al. Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats. J Pineal Res 2007, 42:297-309.
9. Marcheselli V.L., Hong S., Lukiw W.J., Tian X.H., Gronert K., Musto A., et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 2003, 278:43807-43817.
10. Hurn P.D., Subramanian S., Parker S.M., Afentoulis M.E., Kaler L.J., Vandenbark A.A., et al. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab 2007, 27:1798-1805.
11. Schuette-Nuetgen K., Strecker J.K., Minnerup J., Ringelstein E.B., Schilling M. MCP-1/CCR-2-double-deficiency severely impairs the migration of hematogenous inflammatory cells following transient cerebral ischemia in mice. Exp Neurol 2012, 233:849-858.
12. Soriano S.G., Coxon A., Wang Y.F., Frosch M.P., Lipton S.A., Hickey P.R., et al. Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury. Stroke 1999, 30:134-139.
13. Yenari M.A., Kunis D., Sun G.H., Onley D., Watson L., Tuner S., et al. Hu23f2g, an antibody recognizing the leukocyte cd11/cd18 integrin, reduces injury in a rabbit model of transient focal cerebral ischemia. Exp Neurol 1998, 153:223-233.
14. Cao D., Yang B., Hou L., Xu J., Xue R., Sun L., et al. Chronic daily administration of ethyl docosahexaenoate protects against gerbil brain ischemic damage through reduction of arachidonic acid liberation and accumulation. J Nutr Biochem 2007, 18:297-304.
15. Choi-Kwon S., Park K.A., Lee H.J., Park M.S., Lee J.H., Jeon S.E., et al. Temporal changes in cerebral antioxidant enzyme activities after ischemia and reperfusion in a rat focal brain ischemia model: effect of dietary fish oil. Dev Brain Res 2004, 152:11-18.
16. de Wilde M.C., Farkas E., Gerrits M., Kiliaan A.J., Luiten P.G.M. The effect of n-3 polyunsaturated fatty acid-rich diets on cognitive and cerebrovascular parameters in chronic cerebral hypoperfusion. Brain Res 2002, 947:166-173.
17. Katsumata T., Katayama Y., Obo R., Muramatsu H., Ohtori T., Terashi A. Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model. Eur J Pharmacol 1999, 372:167-174.
18. Xue B., Yang Z., Wang X., Shi H. Omega-3 polyunsaturated fatty acids antagonize macrophage inflammation via activation of AMPK/SIRT1 pathway. PLoS ONE 2012, 7:e45990.
19. Yang Y.C., Lii C.K., Wei Y.L., Li C.C., Lu C.Y., Liu K.L., et al. Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-κB pathways. J Nutr Biochem 2013, 24:204-212.
20. Zúňiga J., Cancino M., Medina F., Varela P., Vergas R., Tapia G., et al. N-3 PUFA supplementation triggers PPAR-α activation and PPAR-α/NF-κB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury. PLoS ONE 2011, 6:e28502.
21. Pan H.C., Kao T.K., Ou Y.C., Yang D.Y., Yen Y.J., Wang C.C., et al. Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J Nutr Biochem 2009, 28:715-725.
22. Wang Y.Y., Chen C.J., Lin S.Y., Chuang Y.H., Sheu W.H., Tung K.C. Hyperglycemia is associated with enhanced gluconeogenesis in a rat model of permanent cerebral ischemia. Mol Cell Endocrinol 2013, 367:50-56.
23. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-89.
24. Pan H.C., Yang D.Y., Ou Y.C., Ho S.P., Cheng F.C., Chen C.J. Neuroprotective effect of atorvastatin in an experimental model of nerve crush injury. Neurosurgery 2010, 67:376-389.
25. Chen C.J., Ou Y.C., Lin S.Y., Raung S.L., Liao S.L., Lai C.Y., et al. Glial activation involvement in neuronal death by Japanese encephalitis virus infection. J Gen Virol 2010, 91:1028-1037.
26. Li Y., He D., Zhang X., Liu Z., Zhang X., Dong L., et al. Protective effect of celastrol in a rat cerebral ischemia model: down-regulating p-JNK, p-c-Jun and NF-κB. Brain Res 2012, 1464:8-13.
27. Liu Y., Wang H., Zhu Y., Chen L., Qu Y., Zhu Y. The protective effect of nordihydroguaiaretic acid on cerebral ischemia/reperfusion injury is mediated by the JNK pathway. Brain Res 2012, 1445:73-81.
28. Nijboer C.H., van der Kooij M.A., van Bel F., Ohl F., Heijnen C.J., Kavelaars A. Inhibition of the JNK/AP-1 pathway reduces neuronal death and improves behavioral outcome after neonatal hypoxic-ischemic brain injury. Brain Behav Immun 2010, 24:812-821.
29. Lee I.S., Lim J., Gal J., Kang J.C., Kim H.J., Kang B.Y., et al. Anti-inflammatory activity of xanthohumol involves heme oxygenase-1 induction via NRF2-ARE signaling in microglial BV2 cells. Neurochem Int 2011, 58:153-160.
30. Moreira T.J.T.P., Cebere A., Cebers G., Ostenson C.G., Efendic S., Liljequist S. Reduced HO-1 protein expression is associated with more severe neurodegeneration after transient ischemia induced by cortical compression in diabetic Goto-Kakizaki rats. J Cereb Blood Flow Metab 2007, 27:1710-1723.
31. Poss K.D., Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A 1997, 94:10925-10930.
32. Shah Z.A., Li R., Ahmad A.S., Kensler T.W., Yamamoto M., Biswal S., et al. The flavanol (-)-epicatechin prevents stroke damage through the Nrf2/HO-1 pathway. J Cereb Blood Flow Metab 2010, 30:1951-1961.
33. Tanaka N., Ikeda Y., Ohta Y., Deguchi K., Tian F., Shang J., et al. Expression of Keap1-Nrf2 system and antioxidative proteins in mouse brain after transient middle cerebral artery occlusion. Brain Res 2011, 1370:246-253.
34. Garcia J.H., Liu K.F., Yoshida Y., Lian J., Chen S., del Zoppo G.J. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol 1994, 144:188-199.
35. Stoll G., Jander S., Schrocter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 1998, 56:149-171.
36. Connolly E.S., Winfree C.J., Springer T.A., Naka Y., Liao Y., Yan S.D., et al. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion: role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest 1996, 97:209-216.
37. Kao T.K., Ou Y.C., Raung S.L., Chen W.Y., Yen Y.J., Lai C.Y., et al. Graptopetalum paraguayense E. Walther leaf extracts protect against brain injury in ischemic rats. Am J Chin Med 2010, 38:495-516.
38. Satoh S., Kobayashi T., Hitomi A., Ikegaki I., Suzuki Y., Shibuya M., et al. Inhibition of neutrophil migration by a protein kinase inhibitor for the treatment of ischemic brain infarction. Jpn J Pharmacol 1999, 80:41-48.
39. Lu D.Y., Tsao Y.Y., Leung Y.M., Su K.P. Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids. Neuropsychopharmacology 2010, 35:2238-2248.
40. Titos E., Rius B., González-Périz A., López-Vicario C., Morán-Salvador E., Martinez-Clemente M., et al. Resolin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J Immunol 2011, 187:5408-5418.
41. Wang H., Khor T.O., Saw C.L., Lin W., Wu T., Huang Y., et al. Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid. Mol Pharm 2010, 7:2185-2193.
42. Yates C.M., Tull S.P., Madden J., Calder P.C., Grimble R.F., Nash G.B., et al. Docosahexaenoic acid inhibits the adhesion of flowing neutrophils to cytokine stimulated human umbilical vein endothelial cells. J Nutr 2011, 141:1331-1334.
43. Clausen B.H., Lambersten K.L., Babcock A.A., Holm T.H., Dagnaes-Hansen F., Finsen B. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 2008, 5:46.
44. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19:312-318.
45. Ichihara S., Yamada Y., Liu F., Murohara T., Itoh K., Yamamoto M., et al. Ablation of the transcription factor Nrf2 promotes ischemia-induced neovascularization by enhancing the inflammatory response. Arterioscler Thromb Vasc Biol 2010, 30:1553-1561.
46. Innamorato N.C., Rojo A.I., Garcia-Yague A.J., Yamamoto M., de Ceballos M.L., Cuadrado A. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol 2008, 181:680-689.
47. Leonard M.O., Kieran N.E., Howell K., Burne M.J., Varadarajan R., Dhakshinamoorthy S., et al. Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J 2006, 20:E2166-E2176.
48. Panahian N., Yoshiura M., Maines M.D. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J Neurochem 1999, 72:1187-1203.
49. Dang J., Brandenburg L.O., Rosen C., Fragoulis A., Kipp M., Pufe T., et al. Nrf2 expression by neurons, astroglia, and microglia in the cerebral cortical penumbra of ischemic rats. J Mol Neurosci 2012, 46:578-584.
50. Jeong G.S., Lee D.S., Kim D.C., Jahng Y., Son J.K., Lee S.H., et al. Neuroprotective and anti-inflammatory effects of mollugin via up-regulation of heme oxygenase-1 in mouse hippocampal and microglial cells. Eur J Pharmacol 2011, 654:226-234.
51. Lee I.S., Ryu D.K., Lim J., Cho S., Kang B.Y., Choi H.J. Artesunate activates Nrf2 pathway-driven anti-inflammatory potential through ERK signaling in microglial BV2 cells. Neurosci Lett 2012, 509:17-21.
52. Son T.G., Camandola S., Arumugam T.V., Cutler R.G., Telljohann R.S., Mughal M.R., et al. Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia. J Neurochem 2010, 112:1316-1326.
53. Yalniz M., Demirel U., Orhan C., Bahcecioglu I.H., Ozercan I.H., Aygun C., et al. Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats. Inflammation 2012, 35:1213-1221.
54. Ping Z., Liu W., Kang Z., Gai J., Wang Q., Cheng N., et al. Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme. Brain Res 2010, 1343:178-185.